Exclusive

Bitcoin and power lines

Time to talk about crypto – and its effects on the...

The Spanish town of Marbella will host the seventh annual InterEcoForum next month, dedicated to sustainable development and applied blockchain technologies. The charming Andalusian town...
Dame Helen Alexander

Obituary: Dame Helen Alexander

Businesswoman was a brilliant leader and trailblazer for women in senior boardroom roles… TRIBUTES have been paid to Dame Helen Alexander – a true pioneer...
Sky logo

Murdoch Takeover Stalls

Sky buy out delayed as UK Government intervenes amid calls for investigation over White House ‘fake news’ story… THE drawn-out takeover of broadcaster Sky by...
Adam Bain

Is Twitter falling off its perch?

Departure of Adam Bain may have left social media giant rudderless By Darren Parkin "MR. Bain will remain at Twitter in the coming weeks to assist...

Jaguar warns of investment cuts over Brexit concerns

BRITISH car manufacturers have been fretting over a no-deal or hard Brexit since the controversial referendum. Jaguar Land Rover (JLR) company executives are warning of...
Kwon Oh-joon

Kwon Oh-joon named VP of World Steel Association

Posco chief being lined up to lead steelmaking through potentially turbulent years ahead… By Darren Parkin KWON Oh-joon, CEO of South Korean steel manufacturer Posco, has...
Volvo XC60

Swede Electric Dreams

Is Volvo’s bid to become all-electric the shrewdest business move of the year, or a cynical ploy to capitalise on the world’s mounting affection...
Yemeni Military Shibam

Drug cartels, weapons, banks and the Greenback — illicit trade continues,...

Major banks are unwittingly laundering drug money to fund international arms deals, a former US Senate candidate tells BV editor HAL WILLIAMS US BUSINESS intelligence...
Etihad Airbus A380

Etihad Swoop For Tony Douglas As New CEO

Former military defence expert is to take up the role in January, but can he stop the rot in Abu Dhabi where the airline...
Gene therapy

Merger brings gene therapy aid for infants closer to production

FDA approves ‘breakthrough therapy’ designation for novel treatment NOVARTIS has announced a multi-billion dollar agreement and plan of merger with AveXis to acquire the US-based...